Clinical Trial Update: Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects. [Phase 2]

View source ↗

Summary

Phase 2 extension study assessing immunogenicity and safety of a second dose of GBS Trivalent Vaccine in healthy non-pregnant adults; completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection Due to Streptococcus Group
• Streptococcus Agalactiae Infection

Drugs mentioned

• GBS Trivalent Vaccine (Group B Streptococcus vaccine (trivalent))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bacterial Infection Due to Streptococcus, Group B, Streptococcus Agalactiae | Phase 2 | Status: COMPLETED | Results posted: 2018-07-16